Vivos Therapeutics, Inc. (VVOS) Misses Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts VVOS Hot Sheet
Join SI Premium – FREE
Vivos Therapeutics, Inc. (NASDAQ: VVOS) reported Q3 EPS of ($0.26), $0.01 worse than the analyst estimate of ($0.25). Revenue for the quarter came in at $4.2 million versus the consensus estimate of $3.72 million.
For earnings history and earnings-related data on Vivos Therapeutics, Inc. (VVOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Ennis (EBF) Misses Q2 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
